Suggestion for Practice by Jasna Lipozenčić
Sug ges tion for Prac tice
Ther apy for chronic id io pathic ur ti caria (CIU) is
usu ally quite frus trat ing for the pa tient, and in chil -
dren also for his/her fam ily, caus ing con sid er able
qual ity of life im pair ment. Un sat is fac tory re sponse
to an ti his ta mines dur ing a long pe riod in re frac tory
cases sug gests an al ter na tive to stan dard ther apy.
Be fore ad min is ter ing an immunosuppressant, i.e.
pred ni sone (1 mg/kg/day) for two weeks, other ther -
a peu tic op tions such as leukotriene mod i fi ers
(monte lukast) (5 mg/day) should be tried. We had
four pa tients who re sponded to this ther apy.
The ef fi cacy of leukotriene re cep tor an tag o nists
has been dem on strated in sev eral stud ies, al -
though the role of leukotrienes in ur ti caria is not
com pletely clar i fied. H2 an ti his ta mines were of ten
use ful ad juncts in the treat ment of CIU. There fore,
com bined man age ment is at tempted to help our pa -
tients af ter neg a tive clin i cal his tory, neg a tive for al -
ler gic dis eases/asthma, atopic der ma ti tis, high fe -
ver, drug al lergy, neg a tive rou tine lab o ra tory pa ram -
e ters, skin prick test re sults to aeroallergens and
com mon food al ler gens, neg a tive fo cal re sults. To
avoid longterm use of corticosteroids or cyclosporin 
A, it is sug gested to fol low the re port by D. Vita, G.
Passalacqua, L. Caminiti, G. Barberio and G.B.
Pajno from Messina (It aly), “Suc cess ful com bined
ther apy for re frac tory chronic urticaria in a 10-year-
 old boy” (Allergy 2004;59(9):1021-2).
The reg i men is as fol lows: month 1: å-amino cap -
roic acid (100 mg/kg/day); montelukast (5 mg/ day);
ranitidine (6 mg/kg/day); month 2: montelu kast (5
mg/day); ranitidine (6 mg/kg/day); and month 3:
ranitidine (6 mg/kg/day).
We pro pose this reg i men as an al ter na tive to
stan dard ther apy of CIU.
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